- In preclinical models, simultaneous inhibition of LAG-3 and PD-1 showed synergistic antitumor activity. This phase 2-3 study evaluated the combination of relatlimab (anti LAG-3) and nivolumab […]
- Pembrolizumab in combination with chemotherapy is already FDA-approved for the treatment of patients with triple-negative breast cancer – in the setting of early or metastatic diseases. […]
- This phase III study demonstrates that the combination of paclitaxel and carboplatin is non-inferior to the combination of paclitaxel and ifosfamide for the treatment of patients […]
Levantinib in combination with pembrolizumab in second line treatment the advanced stage endometrial cancerPhase III data from the 309- KEYNOTE-775 study demonstrate that the combination of levantinib plus pembrolizumab was beneficial for patients with advanced endometrial cancer who had […]
OncoAmericas is responsible for MD Health’s operations in Latin and North America. Our mission is to promote independently and innovatively the dissemination of medical oncology education to healthcare professionals, helping to improve the cancer patient’s journey. The group has several specialists in the most diverse sectors of cancer treatment and support areas in order to offer the best solution for professionals and companies in Oncology Market.